MDs (mitochondrial diseases) are a clinically heterogeneous group of disorders characterized by impairment of the respiratory chain function with altered oxidative phosphorylation. We tested the hypothesis that the function of vascular endothelium is affected by increased oxidative stress in MDs. A total of 12 patients with MDs and pair-matched controls were studied. Endothelial function was assessed by measuring FMD (flow-mediated vasodilation) of brachial and common femoral arteries. The test was repeated after vitamin C (500 mg, twice a day) and E (400 mg, once a day) supplementation for 30 days and 90 days after vitamin withdrawal. FMD was reduced in patients compared with controls [AUC/τ (time-averaged area under the curve) for the brachial artery, 1.05 + − 0.24 compared with 4.19 + − 0.59 % respectively, P < 0.001; AUC/τ for the femoral artery, 0.98 + − 0.19 compared with 2.36 + − 0.29 % respectively, P = 0.001; values are means + − S.E.M.] and correlated (brachial artery) with plasma lactate (r = − 0.63, P < 0.01). Urinary 8-iso-PGF 2α (8-iso-prostaglandin F 2α ) was higher in patients than controls (505.6 + − 85.9 compared with 302.5 + − 38.7 pg/mg of creatinine; P < 0.05) and correlated with plasma lactate (r = 0.70, P < 0.05). Immunohistochemical analysis showed 8-iso-PGF 2α staining in MD-affected striated muscle cells and in blood vessels in muscle biopsies of patients. Antioxidant vitamins transiently restored FMD in patients [ AUC/τ (change in AUC/τ ) for the brachial artery, + 1.38 + − 0.49 %, P < 0.05; AUC/τ for the femoral artery, + 0.98 + − 0.24 %, P < 0.01] but had no effect on FMD in controls (brachial artery, − 1.3 + − 0.63 %; and common femoral artery, − 0.58 + − 0.30 %), thus abolishing the differences between patients and controls. The results of the present study indicate that oxidative stress is increased and is, at least partly, responsible for endothelial dysfunction in MDs.
INTRODUCTION
Impaired oxidative phosphorylation is the hallmark of MDs (mitochondrial diseases), a heterogeneous group of prevalently genetic disorders, characterized by the uncoupling of electron transport and decreased ATP generation through the tricarboxylic acid cycle [1, 2] .
When caused by mtDNA (mitochondrial DNA) mutations, the skeletal muscle, the heart and the central and peripheral nervous system are mostly affected, depending on the degree of mitochondrial heteroplasmy and on the biochemical expression of mtDNA abnormalities in high-energy-requiring tissues [1, 2] . Abnormal focal accumulations of mitochondria in skeletal muscle fibres (ragged red fibres) and lactic acidosis are features of MDs and used as diagnostic markers of the disease [1] .
Oxidative stress may be increased in MDs as a consequence of faulty electron transport and increased generation of ROS (reactive oxygen species) in mitochondria harbouring mtDNA mutations [3] [4] [5] [6] . Previously, we observed that vascular tissue is affected in MDs due to mtDNA mutations, in that patients display increased 3-nitrotyrosine staining in the small vessels in striated muscle biopsies, compared with control subjects matched for age and cardiovascular risk factors [8] . In the same patients, FMD (flow-mediated vasodilation) was decreased, consistently with endothelial dysfunction in conduit and small arteries. These findings suggest that increased oxidative stress might be responsible for altered vascular function and damage in MDs [1, 2] .
MDs due to mtDNA mutations may predispose to vascular disease. Patients affected by MELAS (mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes) carry an increased risk of diabetes, nephropathy and cardiomyopathy; those with MERRF (myoclonus epilepsy and ragged-red fibres) carry increased risk of diabetes mellitus. Patients with CPEO (chronic progressive external ophthalmoplegia) frequently develop cardiomyopathy [1] . Evidence is accumulating that arterial hypertension is also a feature of MDs, associated via maternal lineage with mtDNA mutations [3] [4] [5] [6] [7] [8] . In addition, dysfunction in the mitochondrial respiratory chain contributes to the development of vascular disease in aging and diabetes mellitus by increasing oxidative stress [7] .
The aim of the present study was to confirm that the function of vascular endothelium is altered in mitochondrial respiratory chain disorders and to test whether increased oxidative stress is causally involved. Endothelium-derived NO plays a pivotal role in the maintenance of vascular homoeostasis [9] . Mitochondrial dysfunction may alter NO bioactivity by increasing ROS production through the generation of highly reactive peroxynitrite [10, 11] . FMD was assessed as a proof of altered NO generation/bioactivity [12, 13] . Antioxidant vitamins C and E were administered to the subjects as free radical scavengers to prevent the reaction between ROS and NO [14, 15] . The urinary excretion of 8-iso-PGF 2α (8-iso-prostaglandin F 2α ) was measured as an index of oxidative stress [14] . Immunohistochemistry was performed in muscle biopsies from patients to localize 8-iso-PGF 2α in cells bearing the mutated mtDNA.
MATERIALS AND METHODS

Patients
A total of 12 patients with mitochondrial respiratory chain dysfunction were invited to take part in the present study (see Supplementary Table S1 at http://www.clinsci.org/cs/122/cs1220289add.htm).
mtDNA abnormalities were identified in nine patients; three had MERRF and the A8344G mutation, three had MELAS and the A3243G mutation, one had MIDD (maternally inherited diabetes and deafness) and the A3243G mutation, and two had CPEO and a single deletion. Three patients had morphological signs of mitochondrial myopathy (patient 10 had 5 % of ragged red fibres and cytochrome c oxidase deficiency in 20 % of the fibres; patient 11 had subsarcolemmal mitochondrial accumulations in 3 % of the fibres and cytochrome c oxidase deficiency in 10 % of the fibres; patient 12 had 3 % of ragged red fibres) and three had not yet identified mtDNA mutations.
Patients were not receiving any treatment, except for five patients taking antihypertensive drugs for mildto-moderate hypertension [two subjects were taking an ACE (angiotensin-converting enzyme) inhibitor or a calcium channel blocker, one was taking amiloride hydrochlothiazide and two were taking a combination of ACE inhibitors, β-blockers and thiazide diuretics]. Two patients were taking an oral antidiabetic drug (glibenclamide and gliclazide respectively).
Patients were pair matched for gender (three females), age, lipid profile and the presence of diabetes mellitus with 12 non-affected subjects (Table 1) . Two patients and two controls, who were moderate cigarette smokers (<10 cigarettes/day), were invited to refrain from smoking on the week preceding the study days.
Protocol
Blood and urine samples were collected from patients and controls for the determination of a biochemical profile and the measurement of 8-iso-PGF 2α .
Endothelial function and blood pressure were determined in patients and controls. Vascular and biochemical tests were repeated in patients on two additional occasions: at the end a 30-day period of oral supplementation with antioxidant vitamins and 90 days after the withdrawal of vitamins. Ascorbic acid (500 mg; commercial tablets) was administered twice daily (at 08:00 and 20:00 h) in association with α-tocopherol (400 mg; commercial tablets) given at 08:00 h.
All subjects gave their informed consent according to the Declaration of Helsinki. The study was approved by the Internal Reviewing Board of our Institution.
FMD and echo-Doppler analysis
Endothelial function was investigated according to the model of FMD using a high-resolution ultrasound echo-Doppler (Esaote AU5) with a 7.5 MHz linear transducer. The axial resolution of this probe was 0.05 mm and the ultrasonic calipers were accurate to 0.05 mm. Each patient was investigated at 10:00 h in a controlled environment at 22
• C. After patients had rested for 15 min in the supine position, systolic, diastolic and mean blood pressure, and heart rate were determined every 2 min by an oscillometric recorder (Dinamap model 845; Critikon) positioned on the right arm. To assess the basal values of each haemodynamic test, the average of three blood pressure determinations and heart rate recordings were considered. Common femoral and brachial artery diameters and flow velocity were measured at a fixed position: 1 cm before common femoral artery bifurcation and 1 cm above the elbow fold. Distal hyperaemia was provoked by inflating a sphygmomanometer cuff 50 mmHg above systolic blood pressure for 5 min respectively below the knee and around the left wrist. Haemodynamic measurements, related to FMD, were obtained 30 s and 1, 2, 4, 6 and 8 min after the beginning of distal hyperaemia and were related to the flow velocity increase at the level of investigated arteries. After 30 min, endotheliumindependent vasodilation (i.e. induced by an NO donor) was tested. Changes in brachial and femoral artery diameter were recorded 3 and 5 min after the sublingual administration of NTG (nitroglycerine; 300 μg).
Diameter variations were expressed as percentage of the basal diameter. Global quantitative indexes of flow (endothelium)-dependent and endothelium-independent vasodilation were obtained by calculating the AUC (area under the curve) of change in vessel diameter as a function of time and is expressed as a percentage of change over the baseline vessel diameter. AUC was 'time-averaged' (AUC/τ ) by dividing the results of endotheliumdependent and -independent vasodilation by 8 and 5 min respectively. This average value approximates 'single point' values [16, 17] . The percentage increase in blood flow velocity was calculated on values recorded 30 s after cuff deflation with respect to basal values.
Echo-Doppler investigations of FMD and haemodynamic measurements were carried out by two observers. Intra-individual variability was <15 % in our ultrasound laboratory, calculated as the coefficient of variation by repeating FMD measurements in different dates on the same individuals [16, 17] . Echo-Doppler analysis of the carotid arteries was performed to evaluate the presence of atherosclerotic lesions and to measure the intima-media thickness.
Measurement of urinary 8-iso-PGF 2α
To determine the urinary excretion of 8-iso-PGF 2α , a validated index of in vivo lipid peroxidation and oxidative stress, samples from timed overnight urine collections (from 08:00 to 20:00 h) were prepared [18] . To prevent the formation of 8-iso-PGF 2α in vitro, 1 mmol/l of the antioxidant 4-hydroxy-TEMPO (2,2,6,6-tetramethylpiperidine-N-oxyl) (Sigma) was added to each urine sample and then stored at − 80
• C. Samples were analysed by immunoassay after chromatographic purification, according to procedures described previously [18] . In the first step, acidified urine samples (15 ml) were subjected to open column chromatography using pre-packed octadecylsilane columns (Bond-elut; Varian) and 8-iso-PGF 2α was eluted with ethyl acetate. Further purification was performed by HPLC. Separation of 8-iso-PGF 2α from other eicosanoids was obtained by reverse-phase gradient chromatography using octadecylsilane columns (125 solvent module, Beckman; 5S ODS2 Supelco, Sigma-Aldrich) with a mobile phase consisting of water/acetonitrile (7:3, by vol) acidified with trifluoroacetic acid (pH 3). The peak corresponding to 8-iso-PGF 2α was identified on the basis of the retention coefficient K, measured using authentic 8-iso-PGF 2α (Cayman Chemical) and an online UV detector. The percentage recovery of eicosanoids after the chromatographic procedures was determined by measuring the amount of co-eluted 
Immunohistochemistry
All patients were invited to undergo an open muscle biopsy for diagnostic purposes, and ten out of the 12 patients accepted (patients 1, 2, 4-8 and 10-12). Controls muscle biopsies were from ten subjects who were ultimately deemed to be free from muscle diseases. Immunohistochemical studies were performed on serial 6.5-μm-thick cryosections using a rabbit polyclonal antibody to 8-iso-PGF 2α (Abcam), diluted 1:1000. Sections were blocked with normal goat serum before overnight incubation with the primary antibody. The next day, slides were incubated first with the biotinylated antirabbit IgG and then with streptavidin-Texas Red. COX-SDH (cytochrome c oxidase-succinate dehydrogenase) double stain was used to visualize ragged red fibres, indices of excessive mitochondrial proliferation in muscle fibres and a pathological hallmark of MDs [19] . Controls for staining specificity included the omission of the primary antibody or its replacement with non-immune serum at the same concentration.
Biochemical profile
The plasma lactate concentration was determined under resting conditions as a functional marker of altered mitochondrial oxidative phosphorylation [19] . As indices of the oxidant-antioxidant balance, total plasma homocysteine concentration was determined by HPLC after derivatization using fluorescence detection, and plasma vitamins A, C and E were measured by HPLC, using a fluorescence detection system. C-reactive protein, plasma fibrinogen, creatine kinase, vitamin B 12 and folic acid were also measured. A comprehensive biochemical profile was determined using a Technicon DAX 96 automated analyser.
Statistical analysis
The Mann-Withney U test was used for comparisons between patients and controls. The Friedman's test and a two-tailed Wilcoxon signed rank test were used to compare variables in patients with MD before and after the administration of vitamins; the Bonferroni's correction was applied to pair-wise comparisons. The Pearson's coefficient (r) was calculated to explore correlation between the major variables. A P value of 0.05 was considered as statistically significant. Results are presented as means + − S.E.M. in the text and Tables.
RESULTS
FMD and assessment of oxidative stress
No differences were observed as for blood pressure and biochemical profile except for plasma lactate, significantly higher in patients (Table 1) . A statistically significant difference in FMD of brachial and common femoral artery was observed between patients and controls ( Figure 1 ), whereas no difference in endotheliumindependent vasodilation as well as arterial diameters at baseline was present (Supplementary Table S2 at http://www.clinsci.org/cs/122/cs1220289add.htm).
The urinary excretion of 8-iso-PGF 2α was significantly higher in patients with respect to matched controls (505.6 + − 85.9 compared with 302.5 + − 38.7 pg/mg of creatinine, P < 0.05; Supplementary Figure  S1 at http://www.clinsci.org/cs/122/cs1220289add.htm). A correlation between plasma lactate and 8-iso-PGF 2α urinary excretion was observed either when patients were considered alone (n = 12; Figure 2A ) or patients and controls (r = 0.60, P < 0.001; n = 24) were considered together. Plasma lactate inversely correlated with FMD in brachial artery (r = − 0.63, P < 0.01) when both patients and controls were considered together ( Figure 2B ).
As expected, plasma concentrations of vitamins E and C increased after oral supplementation, whereas no changes in the urinary excretion of 8-iso-PGF 2α were observed ( Table 2) . After vitamin supplementation, FMD of common femoral and brachial arteries significantly improved in patients and returned to baseline levels 90 days later (Figure 3 ). These changes occurred in the presence of unmodified arterial diameter and postischaemic flow velocity as well as unaltered endotheliumindependent vasodilation (see Supplementary Table  S2 ). Endothelium-dependent vasodilation did not show statistically significant changes from baseline in control subjects after vitamin supplementation as for brachial artery ( AUC/τ = − 1.3 + − 0.63 %) and common femoral artery ( AUC/τ − 0.58 + − 0.30 %). Therefore the administration of antioxidant vitamins abolished the differences in FMD between patients ( Figure 3 ) and controls (brachial artery after vitamins in controls, AUC/τ 2.93 + − 0.48 %, P = not significant; femoral artery, AUC/τ 1.78 + − 0.82 %, P = not significant).
8-Iso-PGF 2α localization by immunohistochemistry
Staining of 8-iso-PGF 2α was detected in ragged red fibres and in the wall of small blood vessels (inner diameter ranging from 5 to 100 μm) in muscle biopsy from patients (tested patients n = 5; Figures 4B-4D) . Staining of 8-iso-PGF 2α was also observed in sparce capillaries ( Figure 4A ). No abnormal staining was detected in control muscle biopsies with tested antibody (tested controls n = 5).
DISCUSSION
Mitochondrial respiratory chain dysfunction affects oxidative phosphorylation leading to ROS generation. Increased mitochondrial ROS generation in MDs further affects ATP synthesis by hampering enzyme activity [20, 21] . Thus we hypothesized that alterations in local vascular haemodynamics, related to a pro-oxidant To test this hypothesis, endothelial function was studied by measuring FMD. This non-invasive functional test has been used to investigate the release and bioactivity of NO in peripheral vasculature, since vasodilation is specifically prevented by the administration of endothelial NO synthase inhibitors [22] . The alteration in FMD observed in MD patients is accompanied by a preserved vasodilatory response to sublingual NTG, thus indicating that structural changes in the vascular wall or reduced relaxant capacity of smooth muscle cells are unlikely to be responsible for the altered vascular response. It is worth noting that no differences between patients and controls were present with regard to cardiovascular risk factors (age, lipid profile, plasma glucose, homocysteine, antioxidant vitamins and markers of inflammation).
The present results are consistent with those by Koga et al. [23] , who found impaired FMD in patients affected by MELAS carrying the A3243G mutation in the mitochondrial tRNA leu (UUR).
Interestingly, we observed a significant inverse correlation between FMD in brachial artery and lactate. MDs have a matrilineal transmission and are characterized by heteroplasmy, so that a minimal number of mutated mitochondria are necessary for the disease to be expressed in an individual cell. Thus plasma concentration of lactic acid, a consequence of a faulty respiratory chain, can be considered a marker of mitochondrial damage affecting tissues with high energy expenditure, such as the muscle [19] .
Decreased NO bioactivity, due to the reaction with superoxide anion, may provide an adequate explanation for endothelial dysfunction in MDs [10, 11] . ROS are generated in MDs at two main sites of the respiratory chain: the NADH dehydrogenase (complex I) and the ubiquinol-CoQ oxidoreductase (complex III) [1, 2] . To test the pathobiology of ROS in the setting of MD, antioxidant ascorbic acid and vitamin E were given to patients and controls and partially restored FMD in patients. These antioxidant vitamins have a chain-breaking effect on peroxidation processes and specifically act as peroxynitrite scavengers [15] . Antioxidant vitamins have been shown to improve FMD in the presence of cardiovascular risk factors, such as smoking, hypercholesterolaemia and diabetes mellitus that are also characterized by increased oxidative stress, as assessed by measuring the urinary excretion of 8-iso-PGF 2α [24] [25] [26] [27] [28] . Ascorbic acid restores NO biosynthesis and activity preventing both peroxynitrite generation and tethrahydobiopterin oxidation, thus
Figure 2 Correlation between 8-iso-PGF 2α (A) and FMD (B) and plasma lactate concentrations
Correlation between plasma lactate concentrations and the urinary excretion of 8-iso-PGF 2α in patients with MDs (A) and between lactate and brachial FMD in the whole population (B). Solid line, linear regression; broken lines, 95 % CIs.
allowing coupling of endothelial NO synthase [29] . Consistent with the hypothesis that increased oxidative stress is responsible for endothelial dysfunction in MDs is the observation l-arginine supplementation restores endothelial function in patients with MELAS [23] . This effect may result from the antagonism of l-arginine towards the endogenous NO synthase inhibitor, ADMA (asymmetric dimethylarginine), which is generated in the presence of increased oxidative stress [30] . Thus both antioxidant vitamins and l-arginine may restore endothelial function in MDs by preventing the effects of increased oxidative stress.
To further support the hypothesis that oxidative stress is increased in MDs and is, at least partially, responsible for the altered vascular function, we analysed both the urinary excretion of 8-iso-PGF 2α and its tissue localization in patients and healthy subjects [14, 31] . The urinary excretion of 8-iso-PGF 2α is increased in patients and correlates with plasma lactate concentration, indicating that oxidative stress is related to the severity of MDs. The amount of excreted 8-iso-PGF 2α was not reduced by the administration of vitamins C and E. This is consistent with the notion that antioxidant vitamins C and E, at the doses we used, improve endotheliumdependent vasodilation, but may not effectively prevent lipid peroxidation, as previously observed in other clinical [28, 32] . Immunohistochemical analysis localized 8-iso-PGF 2α in ragged red fibres and in blood vessels from MD patients, suggesting that increased ROS generation, in cells containing dysfunctional mitochondria, may cause lipid peroxidation. A pro-oxidant milieu in the proximity of vessels or mutated mtDNA in endothelial and vascular cells may be responsible for the formation of peroxynitrite where NO synthase is selectively expressed and NO is released. Increased staining for the isoprostane and, as already observed, for peroxynitrite suggest that vascular cells may also contribute to ROS generation [21] . These observations require further mechanistic research to be confirmed.
In conclusion, a number of converging evidence suggests that increased oxidative stress plays a role in the appearance of endothelial dysfunction in MDs, regardless of the clinical phenotype and the genetic mutation. A blunted or absent increase in shear stress-induced, NO-mediated, arterial dilation may result in increased peripheral vascular resistance and altered phenotype of endothelial cells. Indeed, in addition to the clinical evidence, data from experimental models of genetically determined mitochondrial dysfunction indicate an association with cardiovascular alterations including increased blood pressure, atherosclerosis and premature aging [1, [3] [4] [5] [6] [7] [8] [33] [34] [35] [36] . Antioxidant vitamins are currently used for the treatment of MDs on an empirical basis [37, 38] . We used vitamins C and E in a proof of concept study; properly designed clinical studies with different treatments, addressing the prevention of oxidationinduced organ damage in MDs, are warranted. 
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